Paul Bolaji: Phase 2 of the Nigeria National Stroke Registry Is Now Live
Paul Bolaji, Education Lead (Stroke Services) at Dorset County Hospital NHS Foundation Trust, shared on LinkedIn:
‘‘The First Nigerian National Stroke Registry
Phase 2
Happy New Month to everyone!
A huge THANK YOU to all centres that participated in the pilot phase-you laid the foundation for something truly historic.
Now, we’re calling on every interested, eager and ready hospitals to join Phase 2 of the Nigeria National Stroke Registry (NNSR).
Even if you did express your interest in phase 1 and you were not selected for the pilot phase.
Please do kindly do re-apply for phase 2.
We have completed the pilot phase and we are moving jnto the next phase to capture the data of stroke care in Nigeria
- Be part of the movement transforming stroke care in Nigeria
- Help us understand the real challenges in each centre
- Because as they say: ‘What we don’t measure, we don’t improve.’
This is more than a registry – it’s a national collaboration to improve outcomes, drive research, and shape policy.
What’s required?
- Reliable internet access
- Commitment to capture all stroke cases and upload via REDCap
- Participation in onboarding and training
- One form per institution
Deadline: 2 weeks, April 14th 2026
Takes just 3-5 minutes
All information remains confidential
Let’s build the future of stroke care -together.
If your hospital is interested, pls kindly contact me.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series